Uncategorized

Inotek Pharmaceuticals Announces Proposed Public Offering of $50 Million of Convertible Senior Notes due 2021

by Business Wire • 2016/08/01 • 0 Comments

LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek Pharmaceuticals Corporation (NASDAQ: ITEK) announces proposed public offering of $50 million of convertible senior notes due 2021.

Full Story →

← Study Shows Corneal Structural Changes Induced by ReVision Optics’ Raindrop® Near Vision Inlay Significantly Improve Near and Intermediate Vision in Subjects with Presbyopia

Ron Kurtz, MD, and Mark Livingston Join Allegro Ophthalmics’ Board of Directors →

Post navigation